Cargando…

Good efficacy achieved by telitacicept, corticosteroids and immunosuppressants in the treatment of SLE combined with MOG-AD

Detalles Bibliográficos
Autores principales:	Tian, Mengxue, Tang, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627278/ https://www.ncbi.nlm.nih.gov/pubmed/37937177 http://dx.doi.org/10.1093/rap/rkad088

Ejemplares similares

Telitacicept for autoimmune nephropathy
por: Cai, Jingjing, et al.
Publicado: (2023)

Efficacy and safety of Telitacicept in patients with IgA nephropathy
por: Liang, Dongrui, et al.
Publicado: (2023)

Role of telitacicept in the treatment of IgA nephropathy
por: Wu, Lijun, et al.
Publicado: (2023)

Treatment of immunothrombosis dysregulation: high-dose corticosteroids is not the good option
por: Helms, Julie, et al.
Publicado: (2023)

Tumefactive Demyelination—A Rare Presentation of Anti-MOG Syndrome
por: Sivadasan, Sesh, et al.
Publicado: (2022)

Clinical characteristics of MOG antibody disease: two case reports
por: Guan, Yujia, et al.
Publicado: (2021)

BLyS/APRIL dual inhibition for IgG4-RD: a prospective single-arm clinical trial of telitacicept
por: Cai, Shaozhe, et al.
Publicado: (2023)

Reversible Focal Neuromyotonia in SLE
por: Maramattom, Boby Varkey
Publicado: (2020)

Case report: Successful treatment of refractory membranous nephropathy with telitacicept
por: Zhang, Lei, et al.
Publicado: (2023)

Uveitis, optic neuritis and MOG
por: Gupta, Pranjal, et al.
Publicado: (2020)

Anti-MOG associated disease with intracranial hypertension after COVID-19 vaccination
por: Jeantin, Lina, et al.
Publicado: (2022)

SLE presenting with catatonia in an adolescent girl
por: Grover, Sandeep, et al.
Publicado: (2013)

Hydroxychloroquine, TTP, COVID-19, and SLE
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

Bone marrow limited diffuse large B-cell lymphoma following prolonged immunosuppressive therapy with methotrexate and corticosteroids
por: Dhiman, Pravesh, et al.
Publicado: (2018)

Transient Tunnel Vision as Initial Presentation of Anti-MOG Antibody Positive Optic Neuritis
por: Prabhakar, Appaswamy T., et al.
Publicado: (2021)

A new promising biological agent for refractory lupus nephritis: Telitacicept
por: Liu, Shuangyan, et al.
Publicado: (2023)

Efficacy and safety of telitacicept in patients with systemic lupus erythematosus: a multicentre, retrospective, real-world study
por: Jin, Hui-Zhi, et al.
Publicado: (2023)

New Onset Visual Loss in MOG Antibody Disease: Optic Neuritis or Central Serous Retinopathy?
por: James, Joe, et al.
Publicado: (2022)

MOG Antibody Disease with Non-Neurological Involvement: A Chance Coincidence or a Relevant Association
por: Porey, Camelia, et al.
Publicado: (2022)

Cranial Nerve Involvement Apart from Optic Nerve in MOG-Antibody Disease: Putative Mechanisms
por: Reddy, Y. Muralidhar, et al.
Publicado: (2023)

Neuropsychiatric complications of SLE: Raising some issues of concern
por: Pattanayak, Raman Deep, et al.
Publicado: (2011)

Good Results with Individually Adapted Long-Term Immunosuppression Following Alemtuzumab Versus ATG Induction Therapy in Combined Kidney-Pancreas Transplantation: A Single-Center Report
por: Bösmüller, Claudia, et al.
Publicado: (2019)

Positive Predictive Value of MOG-IgG for Clinically Defined MOG-AD Within a Real-World Cohort
por: Manzano, Giovanna S., et al.
Publicado: (2022)

The Treatment of Acquired Hemophilia with Combination Therapy of Immunosuppressives and Immunoadsorption
por: Uğur Bilgin, Aynur, et al.
Publicado: (2014)

Improved detection of MOG antibody-associated transverse myelitis with 18F-FDG-PET: a case report
por: Daems, F., et al.
Publicado: (2022)

The prognosis and short-term efficacy of corticosteroid therapy for COVID-19 patients
por: Jia, Xinyu, et al.
Publicado: (2021)

Topical antifungal-corticosteroid fixed-drug combinations: Need for urgent action
por: Rana, Proteesh, et al.
Publicado: (2021)

Randomized Phase 2 Trial of Telitacicept in Patients With IgA Nephropathy With Persistent Proteinuria
por: Lv, Jicheng, et al.
Publicado: (2022)

A Perplexing Presentation of SLE as Adrenal Insufficiency in a Young Male
por: Bargujar, Payal, et al.
Publicado: (2021)

Long-Term Results of Triple Immunosuppression With Tacrolimus Added to Mycophenolate and Corticosteroids in the Treatment of Lupus Nephritis
por: Yap, Desmond Y.H., et al.
Publicado: (2021)

Achieving good adherence to inhaled corticosteroids after weighing canisters of asthmatic children
por: Chuenjit, Wantida, et al.
Publicado: (2017)

HBsAb and HBcAb Have No Significant Effect on the Progression of SLE and RA
por: WANG, Fen, et al.
Publicado: (2017)

Do anti-DFS70 antibodies temper disease activity and progression in SLE?
por: Choi, May Y, et al.
Publicado: (2021)

Assess the precision of ChatGPT's responses regarding systemic lupus erythematosus (SLE) inquiries
por: Huang, Chunyan, et al.
Publicado: (2023)

Do we need a replacement medication for influenza with good efficacy?
por: Arastoo, Mahmoud, et al.
Publicado: (2014)

Letter regarding “Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial”
por: Oyama, Mark A., et al.
Publicado: (2021)

Intraocular pressure: Focus on corticosteroids
por: Shukla, Dhananjay
Publicado: (2021)

Asymptomatic Nontyphoidal Salmonella Bacteriuria in a Patient with SLE Nephritis: An Ominous Threat or Innocent Bystander?
por: Rath, Sutapa, et al.
Publicado: (2019)

Letter regarding "The Efficacy of Intra-Articular Versus Extra-Articular Corticosteroid Injections in the Thumb Carpometacarpal Joint"
por: Herren, Daniel B., et al.
Publicado: (2022)

Letter to the editor regarding “Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial”
por: Atkins, Clarke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8j3ng3dknu3u7tujivp37v6igm